Αποτελέσματα Αναζήτησης
Dosage Form Design Parameters, Volume II, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism.
- Dosage Form Design Considerations
Dosage Form Design Parameters, Volume I, examines the...
- Dosage Form Design Considerations
1 Ιαν 2018 · The chapter focuses on developing the rationale for understanding the role of bulk level properties on the actions of solid particles and their effects on the functionality of the dosage form along with powder flowability and compactibility.
Dosage form design involves the scientific formulation and development of a medication's physical form to ensure optimal delivery, stability, and patient compliance. Key factors in this process include drug solubility, release rate, and administration route, which collectively aim to enhance therapeutic effectiveness while minimizing side effects.
Dosage Form Design Parameters, Volume I, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism.
List reasons for the incorporation of drugs into various dosage forms. Compare and contrast the advantages/disadvantages of various drug dosage forms. Describe the information needed in preformulation studies to characterize a drug substance for possible inclusion into a dosage form.
28 Ιουλ 2018 · Dosage Form Design Parameters, Volume I, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development...
Dosage Form Design Parameters, Volume II, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism.
